Targeting mTORC2-Dependent AKT/FOXO1/RNF125 signaling exploits a therapeutic vulnerability in c-MET-activated and β-catenin-mutated hepatocellular carcinoma.

Journal:

Hepatology

Published:

2025-12-03

DOI:

10.1097/hep.0000000000001637

Affiliations:

15

Authors:

23

Go to article

Institutions	Authors	Share
University of Hawaiʻi Cancer Center, United States of America (USA)	12.000000 12.000000	0.52
West China School of Medicine/West China Hospital of Sichuan University (WCSM/WCH), SCU, China	4.500000	0.20
The Second Affiliated Hospital of Xi'an Jiaotong University, XJTU, China	1.500000	0.07
Zhongnan Hospital, WHU, China	1.000000	0.04
The First Affiliated Hospital of Xi'an Jiaotong University, XJTU, China	1.000000	0.04
University of Regensburg (UR), Germany	1.000000	0.04
Tongji Hospital (TJH), HUST, China	0.500000	0.02
PLA No. 910 Hospital of the Joint Support Force (PLA No. 910 Hospital), China	0.500000	0.02
Huaqiao University (HQU), China	0.500000	0.02
Beijing Hospital, China	0.500000	0.02

Interested in Oncology and Carcinogenesis?